Dongli Liu
7PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 05, 2026
Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer.Dongli Liu, Michelle Wong-Brown, Farhana Amy Sarker
|Nov 26, 2025
Patient-derived epithelial cell organoids mimic the phenotypic complexity of endometriosis subtypes.K Gunther, D Liu, M Cortesi
|Apr 29, 2025
The antibody-drug conjugate targeting ROR1, NBE-002, is active in high-grade serous ovarian cancer preclinical models.Dongli Liu, Cassandra J Vandenberg, Patrizia Sini
|Dec 31, 2024
The Multi-Kinase Inhibitor GZD824 (Olverembatinib) Shows Pre-Clinical Efficacy in Endometrial Cancer.Dongli Liu, Dylan Glubb, Tracy O'Mara
|Apr 23, 2022
The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells.Dongli Liu, Gunnar F Kaufmann, James B Breitmeyer
|Oct 22, 2021
An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles.Nidhi Joshi, Dongli Liu, Kristie-Ann Dickson
Pageof 2
Frequent Collaborators
3 joint publications
Caroline E Ford
2 joint publications
Kristie-Ann Dickson
2 joint publications
Deborah J Marsh
1 joint publications
K Gunther
1 joint publications
M Cortesi
1 joint publications
E Nesbitt-Hawes
1 joint publications
J A Abbott
1 joint publications
Martina H Stenzel
1 joint publications
Tracy O'Mara
1 joint publications
Laura Pisarsky
